Methods
- A 30-minute, web-based quantitative survey was conducted as part of a global research study; this was sent to patients with NASH and patient caregivers identified by quantitative fieldwork specialist organizations in the USA, the UK, Canada, Germany, Japan, and China
- Respondents were aged 18–70 years, and they (or the person they cared for) had been diagnosed with NASH by a medical test, had a healthcare professional currently treating them, and they knew which stage of NASH they were originally diagnosed with and currently in
- Patient progression was measured using the NASH staging system: stage 1 – zone 3 fibrosis; stage 2 – stage 1 + periportal fibrosis; stage 3 – bridging fibrosis; stage 4 – cirrhosis